Your browser doesn't support javascript.
loading
Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor.
Turpin, Anthony; Delliaux, Carine; Parent, Pauline; Chevalier, Hortense; Escudero-Iriarte, Carmen; Bonardi, Franck; Vanpouille, Nathalie; Flourens, Anne; Querol, Jessica; Carnot, Aurélien; Leroy, Xavier; Herranz, Nicolás; Lanel, Tristan; Villers, Arnauld; Olivier, Jonathan; Touzet, Hélène; de Launoit, Yvan; Tian, Tian V; Duterque-Coquillaud, Martine.
Afiliación
  • Turpin A; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.
  • Delliaux C; Department of Medical Oncology, Lille University Hospital, F-59000, Lille, France.
  • Parent P; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.
  • Chevalier H; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.
  • Escudero-Iriarte C; Department of Medical Oncology, Lille University Hospital, F-59000, Lille, France.
  • Bonardi F; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.
  • Vanpouille N; Department of Medical Oncology, Centre Oscar Lambret, 3, rue Frederic Combemale, 59000, Lille, France.
  • Flourens A; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain.
  • Querol J; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000, Lille, France.
  • Carnot A; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.
  • Leroy X; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.
  • Herranz N; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain.
  • Lanel T; Department of Medical Oncology, Centre Oscar Lambret, 3, rue Frederic Combemale, 59000, Lille, France.
  • Villers A; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.
  • Olivier J; Institut de Pathologie, CHU Lille, Avenue Oscar Lambret, F-59000, Lille, France.
  • Touzet H; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain.
  • de Launoit Y; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.
  • Tian TV; Institut de Pathologie, CHU Lille, Avenue Oscar Lambret, F-59000, Lille, France.
  • Duterque-Coquillaud M; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.
Br J Cancer ; 129(12): 1903-1914, 2023 12.
Article en En | MEDLINE | ID: mdl-37875732
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Receptores Androgénicos Límite: Humans / Male Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Receptores Androgénicos Límite: Humans / Male Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido